The implications for Eli Lilly and Novo Nordisk seem pretty clear: The immediate removal of a rival for the massive revenues ...

Shares of companies will injectable GLP-1 drugs already on the market -- Eli Lilly and Novo Nordisk -- gained 2% and 2.7%, respectively, through 10:30 a.m. ET. Viking Therapeutics, which does not ...

Danish drugmaker Novo Nordisk said several hundred counterfeit units of its diabetes drug Ozempic were being distributed in ...

Danish drugmaker Novo Nordisk said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being ...

Several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg have been found in the United States. The FDA ...

Novo Nordisk will pay as much as $2 billion for a new obesity drug called UBT251 The company now holds the exclusive rights to develop, manufacture and sell the drug in much of the world It has ...

In the sleepy suburb of Bagsværd, a 25-minute train ride from Denmark’s capital of Copenhagen, weight-loss drugmaker Novo Nordisk is everywhere. Street after street is filled with the company ...

Bagsværd, Denmark-based Novo Nordisk is a global healthcare company ... Per share NVO boasts an average earnings surprise of 2%. Investors should take the time to consider NVO for their ...

Novo Nordisk Warns Consumers About Counterfeit Versions of Ozempic in US (Reuters) - Danish drugmaker Novo Nordisk said on Monday several hundred counterfeit units of its diabetes drug Ozempic ...

In 2024, Novo Nordisk's Ozempic generated nearly $17 billion in sales and Wegovy brought in around $8 billion. Eli Lilly's Type 2 diabetes drug is Mounjaro and the weight-loss version is Zepbound.

The Food and Drug Administration issued an alert on Monday concerning counterfeit Ozempic that could be in the U.S. drug supply chain. The FDA said the it seized counterfeit medications last week ...